NEXPHORIA
Semaglutide
Long-acting GLP-1 receptor agonist. Metabolic and appetite regulation research.
Purchase Type
Fresh cold-chain delivery every 30 days
Size
Format
For Research Use Only — Not For Human Consumption
This compound is sold exclusively for qualified research purposes. Not approved by the FDA for therapeutic use.
Certificate of Analysis Available
HPLC purity report, MS confirmation, batch documentation.
Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist with 94% sequence homology to native human GLP-1. Two arginine substitutions at positions 8 and 34 confer resistance to DPP-4 degradation, while C18 fatty diacid attachment via a mini-PEG linker to Lys²⁶ enables albumin binding for a plasma half-life of approximately 7 days.
Complete Your Protocol
Related compounds.
Research Overview
Video: Research Background
Educational content from independent researchers and scientists. For research context only — not medical advice.
Research Overview
Semaglutide (Ozempic, Wegovy, Rybelsus) — Mechanisms of Action and Pharmacology
Pharmacology Animation
Animated pharmacology breakdown of how semaglutide works as a GLP-1 receptor agonist: receptor signaling, insulin secretion, appetite suppression, and gastric emptying.
Side-by-Side Analysis
Compare Semaglutide with Similar Compounds
View purity, MW, storage, and pricing side by side.
Frequently Bought Together
Complete Your Protocol
Researchers commonly order these compounds together. Convenient multi-compound ordering.
Weight Management
This itemSemaglutide
5mg
$78
Weight Management
RecommendedAOD-9604
5mg
$53
Weight Management
Tirzepatide
10mg
$120
3 items selected
Uncheck any item to customize your bundle. Discount applied automatically at checkout.
Research Journal
Related Research Articles
Peptide Research for Metabolic Syndrome: Insulin Resistance, Hypertension, and Dyslipidemia Protocols
A comprehensive research guide to metabolic syndrome biology and multi-compound peptide protocols: GLP-1 agonist data from STEP 1 and SELECT, MOTS-c AMPK/ACC mechanism, AOD-9604 β3-AR lipolysis, and NAD+/SIRT1 lipogenesis suppression — with 5-component endpoint battery, 8-group study design, and reconstitution/storage guidance.
GLP-1 Agonists and Appetite Regulation: Hypothalamic Circuits, Ghrelin, and Hunger Endpoint Study Design
A mechanistic deep dive into how GLP-1 agonists suppress appetite through hypothalamic ARC/VMH circuits, ghrelin/GLP-1 axis interplay, gastric emptying, and reward pathway modulation — with validated hunger endpoints and study design for preclinical metabolic research.
Semaglutide Weight Loss Plateau: Research Mechanisms and Protocol Adjustments
A research-focused deep dive into the biological mechanisms underlying weight loss plateaus during GLP-1 agonist treatment. Covers adaptive thermogenesis, counter-regulatory responses, receptor downregulation, and evidence-based protocol design strategies including dose escalation, compound cycling, and combination approaches.
Complete Your Protocol
Metabolic Research Stack
Semaglutide's GLP-1 receptor activation combines with AOD-9604's lipolytic signaling for a dual-mechanism metabolic research protocol.
Weight Management
Semaglutide
5mg
$78
Weight Management
AOD-9604
5mg
$53